 |
59 Diseases |  |
24 Trials |
|
24 Trials |  |
1996 News |  |
| «12...14151617181920212223242526» |
- ||| lacosamide / Generic mfg.
Trial completion, Combination therapy: VICTOS: Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=315, Completed, Sponsor: UCB Pharma GmbH
Active, not recruiting --> Completed
- | lacosamide / Generic mfg.
Enrollment open: Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ?1 Month to <4 Years With Partial-onset Seizures (clinicaltrials.gov) - Jul 23, 2015
P3, N=244, Recruiting, Sponsor: UCB BIOSCIENCES, Inc.
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||||| lacosamide / Generic mfg.
Enrollment open: VALUE: Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures (clinicaltrials.gov) - Jul 2, 2015
P3, N=200, Enrolling by invitation, Sponsor: UCB BIOSCIENCES, Inc.
Not yet recruiting --> Recruiting Not yet recruiting --> Enrolling by invitation
- |||||||||| lacosamide / Generic mfg.
New P3 trial: Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ?1 Month to <4 Years With Partial-onset Seizures (clinicaltrials.gov) - Jun 23, 2015
P3, N=244, Not yet recruiting, Sponsor: UCB BIOSCIENCES, Inc.
- lacosamide / Generic mfg.
Trial completion, Enrollment change: Lacosamid-i.v.-Register (clinicaltrials.gov) - May 28, 2015
P=N/A, N=130, Completed, Sponsor: University of Schleswig-Holstein
Not yet recruiting --> Enrolling by invitation Recruiting --> Completed | N=200 --> 130
- || lacosamide / Generic mfg.
Enrollment closed, Combination therapy: VICTOS: Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat (clinicaltrials.gov) - May 12, 2015
P=N/A, N=374, Active, not recruiting, Sponsor: UCB Pharma GmbH
Recruiting --> Completed | N=200 --> 130 Recruiting --> Active, not recruiting
- |||||| lacosamide / Generic mfg.
Enrollment open: VALOR: A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications (clinicaltrials.gov) - May 3, 2015
P3, N=200, Recruiting, Sponsor: UCB BIOSCIENCES, Inc.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- ||||| lacosamide / Generic mfg., phenytoin / Generic mfg.
New P4 trial: Comparative Trial of IV Lacosamide Versus Phenytoin for Seizure Management (clinicaltrials.gov) - Apr 6, 2015
P4, N=52, Recruiting, Sponsor: Lawson Health Research Institute
- |||||||||| lacosamide / Generic mfg.
New P3 trial, New P4 trial: VALOR: A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications (clinicaltrials.gov) - Apr 3, 2015
P3, N=200, Not yet recruiting, Sponsor: UCB BIOSCIENCES, Inc.
- |||||||||| lacosamide / Generic mfg.
New P3 trial: VALUE: Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures (clinicaltrials.gov) - Apr 3, 2015
P3, N=200, Not yet recruiting, Sponsor: UCB BIOSCIENCES, Inc.
- lacosamide / Generic mfg.
Enrollment open: Lacosamide in Preventing Seizures in Participants With Malignant Glioma (clinicaltrials.gov) - Mar 31, 2015
P=N/A, N=302, Recruiting, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Recruiting Active, not recruiting --> Recruiting
- lacosamide / Generic mfg.
Enrollment closed: Lacosamide in Preventing Seizures in Participants With Malignant Glioma (clinicaltrials.gov) - Mar 25, 2015
P=N/A, N=302, Active, not recruiting, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Recruiting Recruiting --> Active, not recruiting
- |||| lacosamide / Generic mfg., carbamazepine / Generic mfg., carbamazepine ER tablet / Generic mfg.
Trial primary completion date, Monotherapy: SP0993: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older (clinicaltrials.gov) - Mar 9, 2015
P3, N=878, Active, not recruiting, Sponsor: UCB BIOSCIENCES GmbH
Recruiting --> Active, not recruiting Trial primary completion date: Feb 2015 --> Jul 2015
- |||||||||| New P3 trial, Adverse events: Pharmacovigilance in Gerontopsychiatric Patients (clinicaltrials.gov) - Mar 2, 2015
P3, N=2000, Recruiting, Sponsor: Hannover Medical School
- ||| lacosamide / Generic mfg.
Enrollment closed, Trial primary completion date: Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy (clinicaltrials.gov) - Feb 6, 2015
P4, N=55, Active, not recruiting, Sponsor: The Cleveland Clinic
Trial primary completion date: Feb 2015 --> Jul 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Jun 2015
- lacosamide / Generic mfg., fosphenytoin / Generic mfg.
Enrollment closed, Enrollment change, Trial primary completion date: Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures (clinicaltrials.gov) - Jan 26, 2015
P2, N=74, Active, not recruiting, Sponsor: Aatif Husain
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2014 --> Jun 2015 Recruiting --> Active, not recruiting | N=200 --> 74 | Trial primary completion date: Sep 2014 --> Jun 2015
- lacosamide / Generic mfg.
New P2 trial: Effects of Lacosamide on Post-operative Opioid Requirements After a Total Hip Arthroplasty: (clinicaltrials.gov) - Jan 22, 2015
P2, N=50, Recruiting, Sponsor: Indiana University School of Medicine
- lacosamide / Generic mfg.
Enrollment open, Trial initiation date, Trial primary completion date: Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy (clinicaltrials.gov) - Jan 22, 2015
P3, N=25, Recruiting, Sponsor: Academisch Ziekenhuis Maastricht
Recruiting --> Active, not recruiting | N=200 --> 74 | Trial primary completion date: Sep 2014 --> Jun 2015 Not yet recruiting --> Recruiting | Initiation date: Sep 2013 --> Sep 2014 | Trial primary completion date: Sep 2014 --> Dec 2015
- ||||| lacosamide / Generic mfg.
Enrollment change: Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures (clinicaltrials.gov) - Jan 20, 2015
P3, N=472, Active, not recruiting, Sponsor: UCB Pharma SA
Not yet recruiting --> Recruiting | Initiation date: Sep 2013 --> Sep 2014 | Trial primary completion date: Sep 2014 --> Dec 2015 N=378 --> 472
- lacosamide / Generic mfg.
Enrollment closed, Monotherapy: A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures (clinicaltrials.gov) - Jan 15, 2015
P3, N=10, Active, not recruiting, Sponsor: UCB Japan Co. Ltd.
N=378 --> 472 Recruiting --> Active, not recruiting
- lacosamide / Generic mfg.
Trial completion: Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures (clinicaltrials.gov) - Dec 12, 2014
P3, N=9, Completed, Sponsor: UCB Japan Co. Ltd.
Recruiting --> Active, not recruiting Recruiting --> Completed
- | lacosamide / Generic mfg.
Trial completion, Monotherapy: Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures (clinicaltrials.gov) - Dec 12, 2014
P3, N=322, Completed, Sponsor: UCB Pharma
Recruiting --> Completed Active, not recruiting --> Completed
- ||| lacosamide / Generic mfg.
Enrollment open: VIBES: Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors (clinicaltrials.gov) - Dec 7, 2014
P=N/A, N=100, Recruiting, Sponsor: UCB BIOSCIENCES GmbH
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||| Vimpat (lacosamide) / UCB, Daiichi Sankyo
Clinical: VIBES: Study of Lacosamide as an Adjunctive Drug Treatment for Epilepsy in Patients With Brain Tumors (clinicaltrials.gov) - Oct 27, 2014
P=N/A, N=100, Not yet recruiting, Sponsor: UCB BIOSCIENCES GmbH
- lacosamide / Generic mfg.
Enrollment status: Study to Investigate Lacosamide as Add-on Therapy in Subjects ?4 Years to <17 Years of Age With Partial Onset Seizures (clinicaltrials.gov) - Oct 21, 2014
P3, N=308, Recruiting, Sponsor: UCB Pharma
Not yet recruiting --> Recruiting Recruiting --> Recruiting
- lacosamide / Generic mfg.
Trial primary completion date: Cognitive and Behavioral Effects of Lacosamide (clinicaltrials.gov) - Sep 28, 2014
P4, N=32, Recruiting, Sponsor: Evan Fertig
Recruiting --> Recruiting Trial primary completion date: Dec 2013 --> Dec 2015
- ||||| lacosamide / Generic mfg.
Enrollment closed: Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures (clinicaltrials.gov) - Aug 21, 2014
P3, N=378, Active, not recruiting, Sponsor: UCB Pharma SA
Trial primary completion date: Dec 2013 --> Dec 2015 Recruiting --> Active, not recruiting
- ||||||| lacosamide / Generic mfg.
Trial completion: A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures (clinicaltrials.gov) - Aug 21, 2014
P3, N=548, Completed, Sponsor: UCB Pharma SA
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- || lacosamide / Generic mfg.
Trial primary completion date, Combination therapy: VICTOS: Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat (clinicaltrials.gov) - Jul 25, 2014
P=N/A, N=374, Recruiting, Sponsor: UCB Pharma GmbH
Active, not recruiting --> Completed Trial primary completion date: Jan 2015 --> May 2015
- lacosamide / Generic mfg.
Enrollment closed, Trial primary completion date, Monotherapy: Add on Lacosamide Versus High Dose Monotherapy (clinicaltrials.gov) - Jul 23, 2014
P3, N=20, Active, not recruiting, Sponsor: Brigham and Women's Hospital
Trial primary completion date: Jan 2015 --> May 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2013 --> Dec 2014
- | lacosamide / Generic mfg.
Trial completion, Trial primary completion date: A Multicenter, Open-Label Study To Investigate The Safety And Pharmacokinetics Of Lacosamide In Children With Partial Seizures (clinicaltrials.gov) - Jul 18, 2014
P2, N=47, Completed, Sponsor: UCB, Inc.
Recruiting --> Active, not recruiting | Trial primary completion date: Feb 2013 --> Dec 2014 Recruiting --> Completed | Trial primary completion date: Mar 2015 --> Jul 2014
- | lacosamide / Generic mfg.
New P3 trial: Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures (clinicaltrials.gov) - Jul 17, 2014
P3, N=10, Recruiting, Sponsor: UCB Japan Co. Ltd.
- ||||| lacosamide / Generic mfg.
Trial initiation date: Study to Investigate Lacosamide as Add-on Therapy in Subjects ?4 Years to <17 Years of Age With Partial Onset Seizures (clinicaltrials.gov) - Jun 27, 2014
P3, N=300, Ongoing, Sponsor: UCB BIOSCIENCES, Inc.
Recruiting --> Completed | Trial primary completion date: Mar 2015 --> Jul 2014 Initiation date: Aug 2013 --> Nov 2013
- | lacosamide / Generic mfg.
Trial initiation date: A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures. (clinicaltrials.gov) - Jun 19, 2014
P2, N=50, Ongoing, Sponsor: UCB Biosciences Inc.
Initiation date: Aug 2013 --> Nov 2013 Initiation date: Oct 2013 --> Feb 2014
- || lacosamide / Generic mfg.
Trial primary completion date: VITOBA: Vimpat (clinicaltrials.gov) - May 15, 2014
P=N/A, N=576, Completed, Sponsor: UCB Pharma GmbH
Initiation date: Oct 2013 --> Feb 2014 Trial primary completion date: Jun 2013 --> Jul 2013
- | lacosamide / Generic mfg.
Trial completion date: VITOBA: Vimpat (clinicaltrials.gov) - May 15, 2014
P=N/A, N=576, Completed, Sponsor: UCB Pharma GmbH
Trial primary completion date: Jun 2013 --> Jul 2013 Trial completion date: Jun 2013 --> Jul 2013
- | lacosamide / Generic mfg.
New P3 trial, Monotherapy: A Trial to Evaluate the Long Term Safety and Tolerability of Lacosamide Taken as Monotherapy in Adults With Partial-onset Seizures (clinicaltrials.gov) - Apr 24, 2014
P3, N=10, Recruiting, Sponsor: UCB Japan Co. Ltd.
- |||| lacosamide / Generic mfg., carbamazepine / Generic mfg., carbamazepine ER tablet / Generic mfg.
Trial primary completion date, Monotherapy: SP0993: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older (clinicaltrials.gov) - Apr 22, 2014
P3, N=878, Active, not recruiting, Sponsor: UCB BIOSCIENCES GmbH
Trial completion date: Jun 2013 --> Jul 2013 Trial primary completion date: Jan 2015 --> Nov 2014
- ||| lacosamide / Generic mfg., carbamazepine / Generic mfg., carbamazepine ER tablet / Generic mfg.
Trial completion date, Monotherapy: SP0993: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older (clinicaltrials.gov) - Apr 22, 2014
P3, N=878, Active, not recruiting, Sponsor: UCB BIOSCIENCES GmbH
Trial primary completion date: Jan 2015 --> Nov 2014 Trial completion date: Jul 2015 --> Apr 2015
- ||||| lacosamide / Generic mfg., carbamazepine / Generic mfg., carbamazepine ER tablet / Generic mfg.
Enrollment closed, Monotherapy: SP0993: Trial Comparing the Efficacy and Safety of Lacosamide (LCM) to Carbamazepine Controlled-Release (CBZ-CR); Initial Monotherapy in Epilepsy; Subjects Aged 16 and Older (clinicaltrials.gov) - Apr 22, 2014
P3, N=878, Active, not recruiting, Sponsor: UCB BIOSCIENCES GmbH
Trial completion date: Jul 2015 --> Apr 2015 Recruiting --> Active, not recruiting
- |||||| lacosamide / Generic mfg.
Enrollment open: A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures (clinicaltrials.gov) - Feb 27, 2014
P3, N=500, Enrolling by invitation, Sponsor: UCB, Inc.
Recruiting --> Active, not recruiting Not yet recruiting --> Enrolling by invitation
- ||||| lacosamide / Generic mfg.
Enrollment closed: A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures (clinicaltrials.gov) - Feb 3, 2014
P3, N=540, Active, not recruiting, Sponsor: UCB Pharma SA
Not yet recruiting --> Enrolling by invitation Recruiting --> Active, not recruiting
- || lacosamide / Generic mfg.
Enrollment change: Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects (clinicaltrials.gov) - Jan 22, 2014
P1, N=60, Completed, Sponsor: UCB, Inc.
Recruiting --> Active, not recruiting N=50 --> 60
- ||| lacosamide / Generic mfg.
Trial completion: Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects (clinicaltrials.gov) - Jan 22, 2014
P1, N=60, Completed, Sponsor: UCB, Inc.
N=50 --> 60 Active, not recruiting --> Completed
- ||||| lacosamide / Generic mfg.
Enrollment change: VERVE: eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam (clinicaltrials.gov) - Jan 13, 2014
P3, N=120, Completed, Sponsor: UCB, Inc.
Active, not recruiting --> Completed N=300 --> 120
- ||||||| lacosamide / Generic mfg.
Trial completion: VERVE: eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam (clinicaltrials.gov) - Jan 13, 2014
P3, N=120, Completed, Sponsor: UCB, Inc.
N=300 --> 120 Active, not recruiting --> Completed
- | lacosamide / Generic mfg.
Trial completion: Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects (clinicaltrials.gov) - Jan 7, 2014
P1, N=26, Completed, Sponsor: UCB Pharma SA
Active, not recruiting --> Completed Recruiting --> Completed
- lacosamide / Generic mfg.
Trial termination: VICTOR: Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide (clinicaltrials.gov) - Dec 9, 2013
P3, N=11, Terminated, Sponsor: UCB, Inc.
Recruiting --> Completed Recruiting --> Terminated; Slow progress despite recruitment boosting efforts e.g., expert advice obtained from leading study center Investigators; decision thus made to terminate.
- lacosamide / Generic mfg.
Enrollment change: VICTOR: Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide (clinicaltrials.gov) - Dec 9, 2013
P3, N=11, Terminated, Sponsor: UCB, Inc.
Recruiting --> Terminated; Slow progress despite recruitment boosting efforts e.g., expert advice obtained from leading study center Investigators; decision thus made to terminate. N=28 --> 11
- | lacosamide / Generic mfg.
New P1 trial: Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects (clinicaltrials.gov) - Nov 14, 2013
P1, N=26, Completed, Sponsor: UCB Pharma SA